Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. L. Lee, Y. H. Liu, C. H. Chen, C. F. Chiu, C. M. Chen, C. M. Shih (Taichung, Taiwan, Province Of China). The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia. Eur Respir J 2006; 28: Suppl. 50, 2075

Member's Comments

No comment yet.

Related content which might interest you: Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia Source: Eur Respir J 2013; 41: 1378-1385 Year: 2013 Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Eosinophilic pneumonia (acute, chronic) Source: Respipedia Article Year: 2017 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Difference of immune response in patients with severe acute pneumonia and lung abscesses Source: Eur Respir J 2004; 24: Suppl. 48, 189s Year: 2004 Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006 BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006 The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013